Laboratory Reference Grade Compounds
Metabolic & Weight Management Peptides

Pemvidutide (10mg Research Vial)

RUO In-VitroLyophilized Powder≥99% Reference Standard
Protocol SOP↓
₱3,800.00
Out of stock
Net Content10MG
InclusionVial + BAC Water
Volume Discounts:Up to 20% OFF
1
SOPReconstitution Telemetry (10MG)
Diluent:mL
Concentration10.00 mg/mLin 1.0mL BAC
Standard Dose1.2 mg – 2.4 mg Weekly SubQSyringe: 24.0 units (0.24 mL)
Scale (1 Unit)100 mcgper 0.01 mL (U-100)
✓ Includes 10mL Bacteriostatic Water USPMonograph SOP →
Pemvidutide (10mg Research Vial)10MG · Vial + BAC Water
₱3,800.00
1
Technical Specification & Protocol Dossier

Analytical Standards & Laboratory Handling

Verified laboratory protocols, reconstitution parameters, and handling guidelines.

P

Pharmacological Profile & Mechanism of Action

Research Monograph

What it is: Pemvidutide (ALT-801) is a synthetic, long-acting dual agonist targeting both the GLP-1 receptor and the Glucagon receptor with an equimolar (1:1) potency ratio, formulated with a site-specific lipid diacid chain.

How it works: GLP-1 activation delivers glycemic stability and central satiety suppression, while concurrent glucagon receptor activation stimulates direct mitochondrial hepatic fat burning (beta-oxidation) and increased resting metabolic rate.

Why researchers study it: Researched in Phase 2 trials (MOMENTUM study) for metabolic dysfunction-associated steatohepatitis (MASH) and profound reduction of hepatic liver fat (over 75% relative reduction).

Compound & Molecular Specifications

Certificate of Analysis Standards
Target CategoryMetabolic Signaling & Incretins
Intended ApplicationLaboratory & In-Vitro Research Only (RUO)
Physical StateLyophilized Solid Powder
CAS Registry Number2413768-45-7
PubChem CID168407421↗
Molecular Weight3702.2 g/mol
Purity Specification≥99.0% (HPLC-grade)
Net Content Options10MG
Inclusion PackagesVial Only, Vial + BAC Water, Analytical Lab Set
Peptide Sequence / FormulaC168H270N44O48